Fundraising Fox

Hakan Goker

Investor

Managing Director at M Ventures

Amsterdam, North Holland, Netherlands

About

Hakan Goker is Managing Director and head of the Biotechnology team at M Ventures, the strategic venture capital fund of Merck KGaA, where he oversees healthcare and life sciences investments. With 15 years of venture investing experience across Atlas Venture, Aescap Venture, and M Ventures since 2013, Goker has been involved in the formation and management of multiple companies including Artios Pharma, Orphazyme, f-Star, Bicycle Therapeutics, Nimbus Discovery, Storm Therapeutics, and Ribometrix. He is responsible for directing M Ventures' portfolio strategy from its Amsterdam headquarters, with additional offices in the US and Israel, focusing on early-stage investments and company creation in transformational biotechnology.

Experience

  1. M VenturesManaging Directorcurrent2021 — present
  2. M VenturesVice President, Head of Healthcare Investments2020 — 2021Amsterdam, North Holland, Netherlands
  3. M VenturesExecutive Investment Director2019 — 2020The Randstad, Netherlands
  4. M VenturesSenior Investment Director2013 — 2018
  5. NRG TherapeuticsBoard Observercurrent2025 — present
  6. TRIMTECH Therapeutics LimitedBoard Membercurrent2025 — present
  7. ReproNovoBoard Membercurrent2024 — present
  8. NouscomBoard Membercurrent2023 — present
  9. Artios Pharma LtdBoard Membercurrent2016 — presentGreater Cambridge Area
  10. iOncturaBoard Member (ex- founding chairman)current2020 — presentGeneva, Switzerland
  11. iOncturaChairman Of The Board2017 — 2020Switzerland
  12. RibometrixBoard Membercurrent2018 — presentRaleigh-Durham-Chapel Hill Area
  13. STORM Therapeutics LimitedBoard Membercurrent2015 — presentGreater Cambridge Area
  14. Asceneuron SABoard Director and previous acting CBO &Observercurrent2013 — presentLausanne, Vaud, Switzerland
  15. BioPartnerAdvisory Board Membercurrent2013 — present
  16. Anglo Nordic Biotechnology and Medtech ConferenceCommittee Chairmancurrent2008 — presentUK and Nordic Regions
  17. ActitheraChairman2021 — 2025Boston, Massachusetts, United States
  18. Forendo Pharma LtdBoard Director2014 — 2021Finland
  19. SynAffix BVBoard Director2013 — 2021Netherlands
  20. Macrophage PharmaBoard Member2017 — 2021United Kingdom

Education

  1. University of LondonPhD, Molecular Genetics1997 — 2000
  2. Association of International Cancer Research (AICR) ScholarDoctor of Philosophy (PhD)1997 — 2000
  3. Chevening/ Commonwealth Scholar1993 — 1996
  4. UCLBSc Hons, Human Genetics1993 — 1996
  5. The English School - North CyprusHigh School1988 — 1993

Skills & more

Board GovernanceBoard OperationVenture Capital48Lifesciences8Investments4Portfolio Management3Fundraising1Business Development3Healthcare2Scientific Analysis1Recruiting1Biotechnology36
+12 moreDrug DiscoveryMolecular BiologyTechnology TransferClinical DevelopmentCorporate DevelopmentStart-upsenterpreneurshipBusiness StrategyPharmaceutical IndustryStrategyEntrepreneurshipR&D

From Hakan's professional profile.

Same school

Shared employers

Colleagues at M Ventures